Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CeriBell, Inc. (CBLL : NSDQ)

• Company Description    CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. Number of Employees: 281

• Price / Volume Information    Yesterday's Closing Price: $11.57 Daily Weekly Monthly 20 Day Moving Average: 254,409 shares Shares Outstanding: 36.66 (millions) Market Capitalization: $424.20 (millions) Beta: 52 Week High: $32.75 52 Week Low: $10.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.87% -3.59% 12 Week -35.00% -40.96% Year To Date -55.29% -60.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 N. PASTORIA AVENUE - SUNNYVALE,CA 94085 USA ph: 800-436-0826 fax: - investors@ceribell.com https://ceribell.com

• General Corporate Information    Officers Xingjuan (Jane) Chao - President; Chief Executive Officer; and Director Rebecca Robertson - Chair of the Board of Directors Scott Blumberg - Chief Financial Officer David Foehr - Senior Vice President; Finance Juliet Tammenoms Bakker - Director Peer Information CeriBell, Inc. (BJCT) CeriBell, Inc. (CADMQ) CeriBell, Inc. (APNO) CeriBell, Inc. (UPDC) CeriBell, Inc. (IMTIQ) CeriBell, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 15678C102 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 36.66 Most Recent Split Date: (:1) Beta: Market Capitalization: $424.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.43 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.56 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 30.66% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.43 Price/Cash Flow: - Price / Sales: 5.48 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -5.56% Sales Growth vs. Year Ago Period: 38.42% vs. Previous Quarter: 3.46% ROE 06/30/25 - -48.42 03/31/25 - -75.76 12/31/24 - -293.24 ROA 06/30/25 - -28.50 03/31/25 - -36.80 12/31/24 - -59.39 Current Ratio 06/30/25 - 13.31 03/31/25 - 17.36 12/31/24 - 16.73 Quick Ratio 06/30/25 - 12.91 03/31/25 - 16.81 12/31/24 - 16.19 Operating Margin 06/30/25 - -63.83 03/31/25 - -62.50 12/31/24 - -61.82 Net Margin 06/30/25 - -63.83 03/31/25 - -62.50 12/31/24 - -61.82 Pre-Tax Margin 06/30/25 - -63.83 03/31/25 - -62.50 12/31/24 - -61.82 Book Value 06/30/25 - 4.76 03/31/25 - 5.02 12/31/24 - 5.34 Inventory Turnover 06/30/25 - 1.44 03/31/25 - 1.79 12/31/24 - 2.51 Debt-to-Equity 06/30/25 - 0.11 03/31/25 - 0.11 12/31/24 - 0.10 Debt-to-Capital 06/30/25 - 10.26 03/31/25 - 9.78 12/31/24 - 9.28

Powered by Zacks Investment Research ©